<?xml version="1.0" encoding="UTF-8" ?>
<?xml-stylesheet type="text/xsl" href="http://articles.mercola.com/utility/FeedStylesheets/rss.xsl" media="screen"?><rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/" xmlns:wfw="http://wellformedweb.org/CommentAPI/"><channel><title>Claritin, Allegra and Zyrtec Could Move Over-the-Counter</title><link>http://articles.mercola.com/sites/articles/archive/2002/03/23/clairitin-allegra-zytec.aspx</link><description>Drugmakers are in a quandary over how to get the most mileage out of their profitable allergy drugs, weighing whether 3 years of exclusivity on over-the-counter sales would stem competition from generics. Last year, the drugmakers opposed a petition to</description><dc:language>en</dc:language><generator>CommunityServer 2008.5 SP1 (Build: 31106.3070)</generator></channel></rss>